Edition:
United Kingdom

Pharmaceuticals

Page 1

Merck KGaA Affirms Versum Deal Expected To Close In Second Half

Tuesday, 18 Jun 2019

June 18 (Reuters) - Merck KGaA ::PLEASED THAT VERSUM STOCKHOLDERS HAVE VOTED IN FAVOR OF US MOVING FORWARD WITH THIS TRANSACTION.TRANSACTION IS EXPECTED TO CLOSE IN THE SECOND HALF OF 2019.

Versum Materials Stockholders Approve Merger With Merck KGaA

Monday, 17 Jun 2019

June 17 (Reuters) - Versum Materials Inc::VERSUM MATERIALS STOCKHOLDERS APPROVE MERGER WITH MERCK KGAA, DARMSTADT, GERMANY.VERSUM MATERIALS INC - VERSUM CONTINUES TO EXPECT TRANSACTION WITH MERCK KGAA TO CLOSE IN SECOND HALF OF 2019.

China's Fosun Mulls Joint Bid For Bayer Animal Health Arm - Bloomberg

Monday, 17 Jun 2019

June 17 (Reuters) - :CHINA'S FOSUN MULLS JOINT BID FOR BAYER ANIMAL HEALTH ARM - BLOOMBERG.

Canopy Growth, Acreage Holdings Remind Shareholders To Vote For Canopy Growth's Plan To Acquire Acreage

Friday, 14 Jun 2019

June 14 (Reuters) - Acreage Holdings Inc ::CANOPY GROWTH AND ACREAGE HOLDINGS REMIND SHAREHOLDERS TO VOTE FOR CANOPY GROWTH'S PLAN TO ACQUIRE ACREAGE.

Roche And Spark Therapeutics Receive Information Request From Federal Trade Commission

Monday, 10 Jun 2019

June 10 (Reuters) - ROCHE HOLDING AG ::ROCHE AND SPARK THERAPEUTICS, INC. RECEIVE REQUEST FOR ADDITIONAL INFORMATION FROM FTC UNDER HART-SCOTT-RODINO ACT AND ANNOUNCE EXTENSION OF TENDER OFFER FOR SHARES OF SPARK THERAPEUTICS, INC..EFFECT OF SECOND REQUEST IS TO EXTEND WAITING PERIOD UNTIL 10 DAYS AFTER ROCHE HAS SUBSTANTIALLY COMPLIED WITH SECOND REQUEST.PARTIES REMAIN COMMITTED TO TRANSACTION.ALL TERMS AND CONDITIONS OF OFFER SHALL REMAIN UNCHANGED DURING EXTENDED PERIOD.

Medcolcanna Enters Agreement To Acquire Interest In Cannabis Oil Refinery

Thursday, 30 May 2019

May 30 (Reuters) - Medcolcanna Organics Inc ::MEDCOLCANNA ENTERS AGREEMENT TO ACQUIRE INTEREST IN CANNABIS OIL REFINERY.MEDCOLCANNA ORGANICS INC - PURSUANT TO AGREEMENT, MEDCOLCANNA WILL ACQUIRE A 20% STAKE IN REFINERYCO.MEDCOLCANNA ORGANICS INC - DEAL FOR US$1 MILLION.

Amgen Announces Public Cash Offer To Shareholders Of Nuevolution

Wednesday, 22 May 2019

May 22 (Reuters) - Amgen::AMGEN ANNOUNCES A RECOMMENDED PUBLIC CASH OFFER TO THE SHAREHOLDERS OF NUEVOLUTION.AMGEN INC SAYS AMGEN OFFERS SEK 32.50 IN CASH FOR EACH SHARE IN NUEVOLUTION.AMGEN INC SAYS TOTAL VALUE OF OFFER AMOUNTS TO APPROXIMATELY SEK 1,610 MILLION, WHICH CORRESPONDS TO APPROXIMATELY USD 167 MILLION.AMGEN INC SAYS OFFER IS NOT SUBJECT TO ANY FINANCING CONDITION. OFFER IS FULLY FINANCED BY CASH ON HAND..AMGEN INC SAYS AMGEN DOES NOT INTEND TO CHANGE COMPOSITION OF NUEVOLUTION'S MANAGEMENT TEAM AND KEY EMPLOYEES FOLLOWING IMPLEMENTATION OF OFFER.

Amgen Announces Public Cash Offer To Shareholders Of Nuevolution

Wednesday, 22 May 2019

May 22 (Reuters) - Amgen::AMGEN ANNOUNCES A RECOMMENDED PUBLIC CASH OFFER TO THE SHAREHOLDERS OF NUEVOLUTION.AMGEN INC SAYS AMGEN OFFERS SEK 32.50 IN CASH FOR EACH SHARE IN NUEVOLUTION.AMGEN INC SAYS TOTAL VALUE OF OFFER AMOUNTS TO APPROXIMATELY SEK 1,610 MILLION, WHICH CORRESPONDS TO APPROXIMATELY USD 167 MILLION.AMGEN INC SAYS OFFER IS NOT SUBJECT TO ANY FINANCING CONDITION. OFFER IS FULLY FINANCED BY CASH ON HAND..AMGEN INC SAYS AMGEN DOES NOT INTEND TO CHANGE COMPOSITION OF NUEVOLUTION'S MANAGEMENT TEAM AND KEY EMPLOYEES FOLLOWING IMPLEMENTATION OF OFFER.

Cegedim, Sanofi data cooperation for healthcare in Europe

Tuesday, 21 May 2019

May 21 (Reuters) - Cegedim SA ::CEGEDIM AND SANOFI ARE ENGAGED IN AN INNOVATIVE COLLABORATION ON REAL WORLD DATA FOR HEALTHCARE IMPROVEMENT IN EUROPE.

Markets

  • Sectors
  • Europe
  • U.S.
  • Asia

Sector Summary